---
figid: PMC3520524__189fig1
figtitle: Ceramide synthesis pathways and the role of fenretinide in the de novo pathway
organisms:
- Aggregatibacter actinomycetemcomitans
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC3520524
filename: 189fig1.jpg
figlink: /pmc/articles/PMC3520524/figure/fig1/
number: F1
caption: Ceramide synthesis pathways and the role of fenretinide in the de novo pathway.
  Ceramides can be generated by de novo, SMase, and salvage pathways. Fenretinide
  is an agonist for SPT, whereas it is an inhibitor for DEGS.
papertitle: Fenretinide inhibited de novo ceramide synthesis and proinflammatory cytokines
  induced by Aggregatibacter actinomycetemcomitans.
reftext: Hong Yu, et al. J Lipid Res. 2013 Jan;54(1):189-201.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.6926094
figid_alias: PMC3520524__F1
figtype: Figure
redirect_from: /figures/PMC3520524__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3520524__189fig1.html
  '@type': Dataset
  description: Ceramide synthesis pathways and the role of fenretinide in the de novo
    pathway. Ceramides can be generated by de novo, SMase, and salvage pathways. Fenretinide
    is an agonist for SPT, whereas it is an inhibitor for DEGS.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CG32052
  - de
  - Coa
  - Spt
  - lace
  - en
  - Spt-I
  - srp
  - sm
  - Sms
  - stumps
  - sph
  - CG5390
  - slow-phase
  - S1P
  - AGXT
  - SMS
  - RAI1
  - DEGS1
  - SFTA3
  - MBTPS1
  - 3-Keto-dihydrosphingosine
  - Dihydrosphingosine
  - Sphingosine 1-phosphate
  - Dihydroceramide
  - Ceramide
  - Serine
  - Sphingomyelin
  - Sphingosine
  - Fenretinide
---
